Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3324)
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,200
Price
$29.32
Total Value
$64.51K
Shares Held After
13,265
% of Holdings
14.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
300
Price
$31.07
Total Value
$9.32K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,348
Price
$30.06
Total Value
$100.64K
Shares Held After
300
% of Holdings
91.8%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
11,352
Price
$29.24
Total Value
$331.95K
Shares Held After
3,648
% of Holdings
75.7%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
162,517
Price
$3.80
Total Value
$617.40K
Shares Held After
12,794,788
% of Holdings
1.3%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
169,265
Price
$3.80
Total Value
$643.04K
Shares Held After
15,301,237
% of Holdings
1.1%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
2,500
Price
$12.95
Total Value
$32.38K
Shares Held After
119,010
% of Holdings
2.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
2,216
Price
$75.95
Total Value
$168.31K
Shares Held After
11,014
% of Holdings
16.7%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
20,105
Price
$75.50
Total Value
$1.52M
Shares Held After
13,230
% of Holdings
60.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
159
Price
$204.26
Total Value
$32.48K
Shares Held After
42,253
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
43
Price
$202.91
Total Value
$8.73K
Shares Held After
42,412
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
79
Price
$202.42
Total Value
$15.99K
Shares Held After
42,455
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
40
Price
$201.24
Total Value
$8.05K
Shares Held After
42,534
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
146
Price
$199.97
Total Value
$29.20K
Shares Held After
42,574
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.45
Total Value
$275.42K
Shares Held After
451,540
% of Holdings
4.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
337
Price
$204.50
Total Value
$68.92K
Shares Held After
41,382
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
963
Price
$203.22
Total Value
$195.70K
Shares Held After
41,719
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
700
Price
$201.90
Total Value
$141.33K
Shares Held After
42,682
% of Holdings
1.6%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,238
Price
$200.94
Total Value
$248.77K
Shares Held After
43,382
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,302
Price
$199.72
Total Value
$260.04K
Shares Held After
44,620
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
460
Price
$198.85
Total Value
$91.47K
Shares Held After
45,922
% of Holdings
1.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,683
Price
$20.97
Total Value
$98.20K
Shares Held After
80,351
% of Holdings
5.5%
Terns Pharmaceuticals, Inc. (TERN)
Kuriakose Emil — Chief Medical Officer
Shares
942
Price
$52.75
Total Value
$49.69K
Shares Held After
105,673
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,000
Price
$65.71
Total Value
$65.71K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
19,000
Price
$65.36
Total Value
$1.24M
Shares Held After
768,780
% of Holdings
2.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
32,916
Price
$48.33
Total Value
$1.59M
Shares Held After
32,916
% of Holdings
50.0%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
105,211
% of Holdings
8.7%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,875
Price
$48.33
Total Value
$90.62K
Shares Held After
42,011
% of Holdings
4.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
25,098
Price
$31.46
Total Value
$789.58K
Shares Held After
432,886
% of Holdings
5.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
34,902
Price
$30.55
Total Value
$1.07M
Shares Held After
457,984
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$596.11
Total Value
$143.07K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$595.29
Total Value
$119.06K
Shares Held After
40,753
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$594.11
Total Value
$261.41K
Shares Held After
40,953
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$592.98
Total Value
$142.32K
Shares Held After
41,393
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$591.64
Total Value
$165.66K
Shares Held After
41,633
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
155
Price
$590.69
Total Value
$91.56K
Shares Held After
41,913
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
469
Price
$589.66
Total Value
$276.55K
Shares Held After
42,068
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
450
Price
$588.63
Total Value
$264.88K
Shares Held After
42,537
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
846
Price
$587.60
Total Value
$497.11K
Shares Held After
42,987
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
247
Price
$586.61
Total Value
$144.89K
Shares Held After
43,833
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$585.11
Total Value
$93.62K
Shares Held After
44,080
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
31
Price
$583.56
Total Value
$18.09K
Shares Held After
44,240
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
602
Price
$582.75
Total Value
$350.82K
Shares Held After
44,271
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
610
Price
$581.72
Total Value
$354.85K
Shares Held After
44,873
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
190
Price
$580.54
Total Value
$110.30K
Shares Held After
45,483
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$579.35
Total Value
$162.22K
Shares Held After
45,673
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$578.56
Total Value
$138.86K
Shares Held After
45,953
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$577.13
Total Value
$207.77K
Shares Held After
46,193
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$576.02
Total Value
$229.83K
Shares Held After
46,553
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
481
Price
$574.87
Total Value
$276.51K
Shares Held After
46,952
% of Holdings
1.0%
Showing 301–350 of 3324 transactions (page 7 of 67)